Gómez-Puerta JA - Search Results

1

Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses.

Florez H, Hernández-Rodríguez J, Carrasco JL, Prieto-González S, Muxi A, Filella X, Ruiz-Gaspà S, Gómez-Puerta JA, Cid M, Espinosa G, Monegal A, Guañabens N, Peris P. Florez H, et al. RMD Open. 2020 Sep;6(2):e001355. doi: 10.1136/rmdopen-2020-001355. RMD Open. 2020. PMID: 32917834 Free PMC article.

2

The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients.

Bucciarelli S, Espinosa G, Asherson RA, Cervera R, Claver G, Gómez-Puerta JA, Ramos-Casals M, Ingelmo M; Catastrophic Antiphospholipid Syndrome Registry Project Group. Bucciarelli S, et al. Ann Rheum Dis. 2006 Jan;65(1):81-6. doi: 10.1136/ard.2005.037671. Epub 2005 May 26. Ann Rheum Dis. 2006. PMID: 15919677 Free PMC article.

3

Camptocormia as a clinical manifestation of mitochondrial myopathy.

Gómez-Puerta JA, Peris P, Grau JM, Martinez MA, Guañabens N. Gómez-Puerta JA, et al. Clin Rheumatol. 2007 Jun;26(6):1017-9. doi: 10.1007/s10067-006-0259-5. Epub 2006 Mar 25. Clin Rheumatol. 2007. PMID: 16565891

4

Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients.

Gómez-Puerta JA, Cervera R, Espinosa G, Aguiló S, Bucciarelli S, Ramos-Casals M, Ingelmo M, Asherson RA, Font J. Gómez-Puerta JA, et al. Semin Arthritis Rheum. 2006 Apr;35(5):322-32. doi: 10.1016/j.semarthrit.2005.07.003. Semin Arthritis Rheum. 2006. PMID: 16616155 Review.

5

Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.

Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gómez-Puerta JA, Ramos-Casals M, Font J, Asherson RA; European Forum on Antiphospholipid Antibodies. Bucciarelli S, et al. Arthritis Rheum. 2006 Aug;54(8):2568-76. doi: 10.1002/art.22018. Arthritis Rheum. 2006. PMID: 16868979 Free article.

6

Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy.

Gómez-Puerta JA, Espinosa G, Miró JM, Sued O, Llibre JM, Cervera R, Font J. Gómez-Puerta JA, et al. Isr Med Assoc J. 2006 Jul;8(7):513-4. Isr Med Assoc J. 2006. PMID: 16889175 Free article. No abstract available.

7

Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome.

Espinosa G, Bucciarelli S, Cervera R, Gómez-Puerta JA, Font J. Espinosa G, et al. Autoimmun Rev. 2006 Dec;6(2):68-71. doi: 10.1016/j.autrev.2006.06.006. Epub 2006 Jul 18. Autoimmun Rev. 2006. PMID: 17138245 Review.

8

Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors.

Bucciarelli S, Cervera R, Espinosa G, Gómez-Puerta JA, Ramos-Casals M, Font J. Bucciarelli S, et al. Autoimmun Rev. 2006 Dec;6(2):72-5. doi: 10.1016/j.autrev.2006.06.007. Epub 2006 Jul 21. Autoimmun Rev. 2006. PMID: 17138246 Review.

9

Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry.

Cervera R, Espinosa G, Bucciarelli S, Gómez-Puerta JA, Font J. Cervera R, et al. Autoimmun Rev. 2006 Dec;6(2):81-4. doi: 10.1016/j.autrev.2006.06.009. Epub 2006 Jul 21. Autoimmun Rev. 2006. PMID: 17138248 Review.

10

Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome.

Gómez-Puerta JA, Cervera R, Espinosa G, Bucciarelli S, Font J. Gómez-Puerta JA, et al. Autoimmun Rev. 2006 Dec;6(2):85-8. doi: 10.1016/j.autrev.2006.06.010. Epub 2006 Jul 20. Autoimmun Rev. 2006. PMID: 17138249 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters